z-logo
Premium
Mice with Deficiency of Gγ 7 in Dopamine D 1 Receptor Expressing Neurons Exhibit a Hypolocomotor Phenotype
Author(s) -
Schwindinger William F.,
Sheridan Kathleen M.,
Yurcaba Lindsay M.,
Robishaw Janet D.
Publication year - 2007
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fasebj.21.5.a430-c
Subject(s) - dopamine , adenosine a2a receptor , adenylyl cyclase , dopamine receptor d2 , medicine , endocrinology , striatum , amphetamine , dopamine receptor d1 , medium spiny neuron , agonist , biology , adenosine receptor , g protein coupled receptor , dopamine receptor , d1 like receptor , neuroscience , receptor
In striatal neurons, dopamine stimulates adenylyl cyclase activity via a heterotrimeric G protein that contains Gα olf and Gγ 7 . Surprisingly, despite impairment of dopamine D 1 receptor stimulated adenylyl cyclase activity in the striatum, Gng7 −/− mice do not display a hypolocomotor phenotype. However, Gng7 −/− mice also show impaired adenosine A 2a receptor signaling in the striatum. To test the hypothesis that normal locomotor activity in Gng7 −/− mice results from a balanced deficit in these two signal transduction pathways, we created mice with deficiency of Gγ 7 specifically in dopamine D 1 receptor expressing neurons. Gng7 fl/fl ; Drd1a Cre/+ mice show reduced locomotion in a behavioral ethogram, reduced exploratory behavior in a novel environment, and a markedly reduced locomotor response to the indirect dopamine agonist amphetamine, but a normal locomotor response to a high dose of the adenosine A 2a receptor antagonist caffeine. These results affirm the importance of Gγ 7 in transducing signals from the dopamine D 1 receptor in the control of locomotor activity. In conjunction with the lack of a locomotor phenotype in Gng7 −/− mice, these results suggest that Gγ 7 coupled, adenosine A 2a receptor mediated signaling may be equally important in regulating locomotor behavior. Our results are consistent with recent studies that have demonstrated a potential role for adenosine A 2a antagonists in the treatment of Parkinson's Disease. Supported by NIH grant GM39867.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom